We are live on ! Find out more
SA

Shilanski & Associates Portfolio holdings

AUM $376M
1-Year Est. Return 19.08%
This Fund
S&P 500
This Quarter Est. Return
+2.08%
1 Year Est. Return
+19.08%
3 Year Est. Return
+84.25%
5 Year Est. Return
+122.72%
10 Year Est. Return
AUM
$297M
AUM Growth
+$6.95M
Cap. Flow
+$3M
Cap. Flow %
1.01%
Top 10 Hldgs %
43.22%
Holding
116
New
11
Increased
38
Reduced
55
Closed
8

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.66M
2
QLYS icon
Qualys
QLYS
+$1.28M
3
MMM icon
3M
MMM
+$768K
4
NUE icon
Nucor
NUE
+$339K
5
AAPL icon
Apple
AAPL
+$281K

Sector Composition

Rank Sector Weight
1 Technology 12.28%
2 Consumer Staples 8.36%
3 Financials 5.83%
4 Industrials 5.37%
5 Healthcare 4.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
101
Oracle
ORCL
$367B
$203K 0.07%
+1,436
New +$178K
FMX icon
102
Fomento Económico Mexicano
FMX
$43.2B
$202K 0.07%
1,879
-29
-2% -$3.39K
PBR.A icon
103
Petrobras Class A
PBR.A
$109B
$185K 0.06%
+12,796
New +$190K
WBA
104
DELISTED
Walgreens Boots Alliance
WBA
$169K 0.06%
13,981
+2,160
+18% +$36.6K
VIPS icon
105
Vipshop
VIPS
$7.3B
$145K 0.05%
11,115
-527
-5% -$8.38K
FNB icon
106
FNB Corp
FNB
$6.76B
$141K 0.05%
10,320
VIV icon
107
Telefônica Brasil
VIV
$20.6B
$120K 0.04%
14,638
-1,929
-12% -$17.4K
NMR icon
108
Nomura Holdings
NMR
$27.9B
$119K 0.04%
+20,636
New +$122K
DIS icon
109
Walt Disney
DIS
$167B
-1,653
Closed -$202K
GOOG icon
110
Alphabet (Google) Class C
GOOG
$4.08T
-1,761
Closed -$268K
IWM icon
111
iShares Russell 2000 ETF
IWM
$80.2B
-974
Closed -$205K
NUE icon
112
Nucor
NUE
$58.5B
-1,713
Closed -$339K
PBR icon
113
Petrobras
PBR
$123B
-12,850
Closed -$195K
PFE icon
114
Pfizer
PFE
$142B
-95,965
Closed -$2.66M
PKX icon
115
POSCO
PKX
$16.5B
-2,720
Closed -$213K
QLYS icon
116
Qualys
QLYS
$4.99B
-7,686
Closed -$1.28M

Similar funds

Shilanski & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Shilanski & Associates held 116 positions worth $297M, up 2.4% from $290M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Shilanski & Associates's Q2 2024 filing shows 11 new, 38 increased, 55 reduced and 8 closed positions. Its largest new stake was WisdomTree Trust WisdomTree US Quality Dividend Growth Fund: 33,382 shares worth $2.61M. The largest sale was Pfizer, an estimated $2.66M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Consumer Staples and Financials.

  • Shilanski & Associates's largest Q2 2024 buy was WisdomTree Trust WisdomTree US Quality Dividend Growth Fund: 33,382 shares worth $2.61M.
  • Shilanski & Associates added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $847K increase.
  • Shilanski & Associates's biggest Q2 2024 reduction was 3M, cutting an estimated $768K.
  • Shilanski & Associates fully exited Pfizer in Q2 2024, selling an estimated $2.66M.
  • Shilanski & Associates's ten largest holdings make up 43% of its $297M portfolio in Q2 2024.
  • Shilanski & Associates opened 11 new positions and closed 8 in Q2 2024.
  • Shilanski & Associates's portfolio value rose 2.4% quarter-over-quarter to $297M.

Based on Shilanski & Associates's 13F filing for Q2 2024, filed 18 Jul 2024.